期刊文献+

SUMO在恶性肿瘤中的表达及其分子机制 被引量:2

Expression of SUMO in Malignant Tumors and Its Molecular Mechanism
下载PDF
导出
摘要 小泛素样修饰物(SUMO)是新近发现的与泛素相似的一种修饰蛋白,其参与的SUMO化修饰是一种动态可逆的蛋白质翻译后修饰,SUMO可通过共价结合不同的底物蛋白,参与调节蛋白质稳定、亚细胞定位、基因转录调控、信号转导及促进蛋白酶体降解等。SUMO化修饰在结肠癌、乳腺癌、前列腺癌等恶性肿瘤的发生、发展以及转移中扮演重要角色,但SUMO在恶性肿瘤发生发展过程中的分子机制及作用尚未完全明确。因此,深入探究SUMO化在各类癌症进程中发挥的作用,将为恶性肿瘤的诊治及预防提供新方法。 Small ubiquitin-like modifier(SUMO)is a newly discovered modified protein similar to ubiquitin,and its SUMOylation modification is a dynamically reversible post-translational modification of protein.SUMO can participate in protein stabilization,subcellular localization,gene transcriptional regulation,signal transduction and promotion of proteasome degradation by covalently binding to different substrate proteins.SUMOylation modification plays an important role in the occurrence,development and metastasis of malignant tumors such as colon cancer,breast cancer and prostate cancer,but the molecular mechanism and role of SUMO in them are not yet fully clarified.Therefore,further study on the role of SUMOylation in various cancer processes which will provide new methods for the diagnosis,treatment and prevention of cancer.
作者 邓思远 贺德 DENG Siyuan;HE De(Graduate College of Guangdong Medical University,Zhanjiang 524023,China;Department of General Surgery,Bao′an Clinical Medical College of Guangdong Medical University/Bao′an People′s Hospital of Shenzhen,Shenzhen 518101,China)
出处 《医学综述》 2020年第17期3434-3438,3443,共6页 Medical Recapitulate
关键词 小泛素样修饰物 SUMO特异性蛋白酶 翻译后修饰 恶性肿瘤 分子机制 Small ubiquitin-like modifier SUMO-specific proteases Post-translational modification Malignant tumor Molecular mechanism
  • 相关文献

参考文献3

二级参考文献22

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 2Burdelski C,Menan D,Tsourlakis MC,et al.The prognostic value of SUMO1/Sentrin specific peptidase 1(SENP1)in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion[J].BMC Cancer,2015(15):538.
  • 3Bawa-Khalfe T,Cheng J,Wang Z,et al.Induction of the SUMOspecific protease 1 transcription by the androgen receptor in prostate cancer cells[J].J Biol Chem,2007,282(52):37341-37349.
  • 4Cheng J,Wang D,Wang Z,et al.SENP1 enhances androgen receptor dependent transcription through desumoylation of histone deacetylase 1[J].Mol Cell Biol,2004,24(13):6021-6028.
  • 5Siegel R,Ma J,Zou Z,et al.Cancer statistics,2014[J].CA Cancer J Clin,2014,64(1):9-29.
  • 6Gill G.SUMO and ubiquitin in the nucleus:different functions,similar mechanisms[J].Genes Dev,2004,18(17):2046-2059.
  • 7Girdwood D,Bumpass D,Vaughan OA,et al.P300 transcriptional repression is mediated by SUMO modification[J].Mol Cell,2003,11(4):1043-1054.
  • 8Wu HJ,Sun L,Zhang Y,et al.Coordinated regulation of AIB1transcriptional activity by sumoylation and phosphorylation[J].J Biol Chem,2006,281(31):21848-21856.
  • 9Wang Q,Xia N,Li T,et al.SUMO-specific protease 1 promotes prostate cancer progression and metastasis[J].Oncogene,2013,32(19):2493-2498.
  • 10Van Nguyen T,Angkasekwinai P,Dou H,et al.SUMO-specific protease 1 is critical for early lymphoid development through regulation of STAT5 activation[J].Mol Cell,2012,45(2):210-221.

共引文献14

同被引文献25

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部